Skip to main content
HR 1656 117th Congress House Armed Forces and National Security Government information and archives Health care costs and insurance Health care coverage and access Mental health Military medicine Military personnel and dependents Neurological disorders Veterans' medical care

TREAT PTSD Act

Introduced: July 13, 2021 Introduced by: Perry, Scott Republican · Pennsylvania See on congress.gov
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 8, 2021
Referred to the Committee on Armed Services, and in addition to the Committee on Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 8, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Treatment and Relief through Emerging and Accessible Therapy for PTSD Act or the TREAT PTSD Act

This bill requires the Department of Veterans Affairs (VA) and the Department of Defense (DOD) to furnish stellate ganglion block to certain veterans or members of the Armed Forces (including reserve components) diagnosed with post-traumatic stress disorder (PTSD). Blocking the stellate ganglion (a group of nerves at the base of the neck) by injecting a local anesthetic is a treatment that may alleviate PTSD symptoms.

The bill authorizes this treatment for any veteran or member of the Armed Forces who (1) is enrolled in the VA health care system or TRICARE program, (2) has been diagnosed with PTSD, and (3) has elected to receive stellate ganglion block after being informed by a physician of the risks and benefits. Such treatment may be furnished at a VA medical center, DOD medical facility, or through health care provider under the Veterans Community Care Program or TRICARE health insurance program.

The bill also requires the VA and DOD to update the VA/DOD Clinical Practice Guideline (CPG) for the Management of PTSD to ensure that information about stellate ganglion block is included.

What's happening now March 8, 2021

Referred to the Committee on Armed Services, and in addition to the Committee on Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1656: TREAT PTSD Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-1656/
MLA
"H.R. 1656: TREAT PTSD Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-1656/.
Bluebook (legal)
H.R. 1656, 117th Cong. (2026), https://openamerica.io/bill/117-HR-1656/.
Markdown link
[H.R. 1656: TREAT PTSD Act](https://openamerica.io/bill/117-HR-1656/)
Report a problem